Literature DB >> 28840385

Nonalcoholic Steatohepatitis: The Second Leading Indication for Liver Transplantation in the USA.

Marcio F Chedid1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28840385     DOI： 10.1007/s10620-017-4724-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  10 in total

Review 1.  The global NAFLD epidemic.

Authors:  Rohit Loomba; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

2.  Increasing Burden of Chronic Liver Disease Among Adolescents and Young Adults in the USA: A Silent Epidemic.

Authors:  Iliana Doycheva; Kymberly D Watt; Ghassoub Rifai; Rachel Abou Mrad; Rocio Lopez; Nizar N Zein; William D Carey; Naim Alkhouri
Journal:  Dig Dis Sci       Date:  2017-02-13       Impact factor: 3.199

3.  Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

Authors:  Michael R Charlton; Justin M Burns; Rachel A Pedersen; Kymberly D Watt; Julie K Heimbach; Ross A Dierkhising
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

4.  Safety and efficacy of current direct-acting antiviral regimens in kidney and liver transplant recipients with hepatitis C: Results from the HCV-TARGET study.

Authors:  Varun Saxena; Vandana Khungar; Elizabeth C Verna; Josh Levitsky; Robert S Brown; Mohamed A Hassan; Mark S Sulkowski; Jacqueline G O'Leary; Farrukh Koraishy; Joseph S Galati; Alexander A Kuo; Monika Vainorius; Lucy Akushevich; David R Nelson; Michael W Fried; Norah Terrault; K Rajender Reddy
Journal:  Hepatology       Date:  2017-09-04       Impact factor: 17.425

Review 5.  De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.

Authors:  Matthew Kappus; Manal Abdelmalek
Journal:  Clin Liver Dis       Date:  2017-02-01       Impact factor: 6.126

6.  Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.

Authors:  George Cholankeril; Robert J Wong; Menghan Hu; Ryan B Perumpail; Eric R Yoo; Puneet Puri; Zobair M Younossi; Stephen A Harrison; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2017-07-25       Impact factor: 3.199

7.  Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors.

Authors:  Marcio F Chedid; Charles B Rosen; Scott L Nyberg; Julie K Heimbach
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

8.  The impact of disease recurrence on graft survival following liver transplantation: a single centre experience.

Authors:  Ian A Rowe; Kerry Webb; Bridget K Gunson; Naimish Mehta; Sayeed Haque; James Neuberger
Journal:  Transpl Int       Date:  2008-01-21       Impact factor: 3.782

9.  Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease.

Authors:  J K Heimbach; K D S Watt; J J Poterucha; N Francisco Ziller; S D Cecco; M R Charlton; J E Hay; R H Wiesner; W Sanchez; C B Rosen; J M Swain
Journal:  Am J Transplant       Date:  2012-11-08       Impact factor: 8.086

10.  DIETARY MANAGEMENT FOR DYSLIPIDEMIA IN LIVER TRANSPLANT RECIPIENTS.

Authors:  Andressa S Pinto; Marcio F Chedid; Léa T Guerra; Daiane D Cabeleira; Cleber D P Kruel
Journal:  Arq Bras Cir Dig       Date:  2016 Nov-Dec
  10 in total
  11 in total

1.  Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model.

Authors:  Yoon Mee Yang; Zhijun Wang; Michitaka Matsuda; Ekihiro Seki
Journal:  Arch Pharm Res       Date:  2021-01-24       Impact factor: 4.946

2.  Hyaluronan synthase 2-mediated hyaluronan production mediates Notch1 activation and liver fibrosis.

Authors:  Yoon Mee Yang; Mazen Noureddin; Cheng Liu; Koichiro Ohashi; So Yeon Kim; Divya Ramnath; Elizabeth E Powell; Matthew J Sweet; Yoon Seok Roh; I-Fang Hsin; Nan Deng; Zhenqiu Liu; Jiurong Liang; Edward Mena; Daniel Shouhed; Robert F Schwabe; Dianhua Jiang; Shelly C Lu; Paul W Noble; Ekihiro Seki
Journal:  Sci Transl Med       Date:  2019-06-12       Impact factor: 17.956

3.  Pre-transplant ALBI Grade 3 Is Associated with Increased Mortality After Liver Transplantation.

Authors:  Nicole Bernardi; Marcio F Chedid; Tomaz J M Grezzana-Filho; Aljamir D Chedid; Marcelo A Pinto; Ian Leipnitz; João E Prediger; Carolina Prediger; Ariane N Backes; Thais O Hammes; Lea T Guerra; Alexandre de Araujo; Mario R Alvares-da-Silva; Cleber R P Kruel
Journal:  Dig Dis Sci       Date:  2019-01-14       Impact factor: 3.199

4.  Can Statin Treatment Reduce the Risk of Hepatocellular Carcinoma? A Systematic Review and Meta-Analysis.

Authors:  Yue Chang; Qinyu Liu; Zidong Zhou; Yuping Ding; Mei Yang; Wei Xu; Kai Chen; Qing Zhang; Zhenguo Wang; Hai Li
Journal:  Technol Cancer Res Treat       Date:  2020 Jan-Dec

5.  Dyslipidemia as a risk factor for liver fibrosis progression in a multicentric population with non-alcoholic steatohepatitis.

Authors:  Nahum Méndez-Sánchez; Eira Cerda-Reyes; Fátima Higuera-de-la-Tijera; Ana K Salas-García; Samantha Cabrera-Palma; Guillermo Cabrera-Álvarez; Carlos Cortez-Hernández; Luis A Pérez-Arredondo; Emma Purón-González; Edgar Coronado-Alejandro; Arturo Panduro; Heriberto Rodríguez-Hernández; Vania C Cruz-Ramón; Alejandro Valencia-Rodríguez; Xingshun Qi; Nashla Hamdan-Pérez; Nancy E Aguilar-Olivos; Beatriz Barranco-Fragoso; Oscar Ramírez-Pérez; Alfonso Vera-Barajas
Journal:  F1000Res       Date:  2020-01-28

6.  Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han population.

Authors:  Fangfei Xie; Hong Zhou; Yun Wang
Journal:  Lipids Health Dis       Date:  2019-09-12       Impact factor: 3.876

7.  Nonalcoholic Fatty Liver Disease and Renal Function Impairment: A Cross-Sectional Population-Based Study on Its Relationship From 1999 to 2016.

Authors:  Michael H Le; Yee Hui Yeo; Linda Henry; Mindie H Nguyen
Journal:  Hepatol Commun       Date:  2019-07-29

8.  Combining I148M and E167K variants to improve risk prediction for nonalcoholic fatty liver disease in Qingdao Han population, China.

Authors:  Li-Zhen Chen; Hong-Yun Ding; Shou-Sheng Liu; Qun Liu; Xiang-Jun Jiang; Yong-Ning Xin; Shi-Ying Xuan
Journal:  Lipids Health Dis       Date:  2019-02-09       Impact factor: 3.876

9.  Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis.

Authors:  Yoon Mee Yang; Masato Fukui; Zhijun Wang; Fiona Miao; Margo J Karriker; Ekihiro Seki
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-23       Impact factor: 5.555

10.  The association of serum total bile acid with non-alcoholic fatty liver disease in Chinese adults: a cross sectional study.

Authors:  Ziyu Zhang; Wen Dai; Shuwei Weng; Mengdie Luo; Jiahao Fu; John A Zadroga; Stefano Spolitu; Daoquan Peng
Journal:  Lipids Health Dis       Date:  2020-02-04       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.